Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A Alper

Showing results (51-60 of 207) with videos related to

Pageof 21
Sort By:
Pediatrics|July 1, 1973
Opsonic activity in the newborn: role of properdinT P Stossel, C A Alper, F S Rosen
Human Immunology|April 1, 1990
Complotypes in pemphigus vulgaris: differences between Jewish and non-Jewish patientsA R Ahmed, E J Yunis, C A Alper
Vox Sanguinis|January 1, 1988
An immunoblotting technique for direct visualization of Chido and Rodgers reactivity on C4 variants after electrophoresisP M Sklarin, Z L Awdeh, C A Alper
The New England Journal of Medicine|March 22, 1973
Increased susceptibility to infection in a patient with type II essential hypercatabolism of C3C A Alper, K J Bloch, F S Rosen
Complement and Inflammation|January 1, 1989
Complotypes and extended haplotypes in laboratory medicineC A Alper, Z L Awdeh, E J Yunis
Clinical Immunology and Immunopathology|April 1, 1991
Decreased inhibition of immune precipitation by sera with the C2 B allotypeL Varga, C A Alper, Z Zam, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1972
Inactivator of the third component of complement as an inhibitor in the properdin pathwayC A Alper, F S Rosen, P J Lachmann
Lancet (London, England)|June 9, 1979
Genetic marker for insulin-dependent diabetes mellitusD Raum, C A Alper, R Stein, et al.
The Journal of Allergy and Clinical Immunology|February 1, 1986
The metabolism of C1 inhibitor and C1q in patients with acquired C1-inhibitor deficiencyJ Melamed, C A Alper, M Cicardi, et al.
Immunogenetics|March 31, 2012
Genetic polymorphism of serum complement components in the chimpanzeeD Raum, H Balner, B H Petersen, et al.
Pageof 21

Showing results (51-60 of 207) with videos related to

Sort By:
Pageof 21
Pediatrics|July 1, 1973
Opsonic activity in the newborn: role of properdinT P Stossel, C A Alper, F S Rosen
Human Immunology|April 1, 1990
Complotypes in pemphigus vulgaris: differences between Jewish and non-Jewish patientsA R Ahmed, E J Yunis, C A Alper
Vox Sanguinis|January 1, 1988
An immunoblotting technique for direct visualization of Chido and Rodgers reactivity on C4 variants after electrophoresisP M Sklarin, Z L Awdeh, C A Alper
The New England Journal of Medicine|March 22, 1973
Increased susceptibility to infection in a patient with type II essential hypercatabolism of C3C A Alper, K J Bloch, F S Rosen
Complement and Inflammation|January 1, 1989
Complotypes and extended haplotypes in laboratory medicineC A Alper, Z L Awdeh, E J Yunis
Clinical Immunology and Immunopathology|April 1, 1991
Decreased inhibition of immune precipitation by sera with the C2 B allotypeL Varga, C A Alper, Z Zam, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1972
Inactivator of the third component of complement as an inhibitor in the properdin pathwayC A Alper, F S Rosen, P J Lachmann
Lancet (London, England)|June 9, 1979
Genetic marker for insulin-dependent diabetes mellitusD Raum, C A Alper, R Stein, et al.
The Journal of Allergy and Clinical Immunology|February 1, 1986
The metabolism of C1 inhibitor and C1q in patients with acquired C1-inhibitor deficiencyJ Melamed, C A Alper, M Cicardi, et al.
Immunogenetics|March 31, 2012
Genetic polymorphism of serum complement components in the chimpanzeeD Raum, H Balner, B H Petersen, et al.
Pageof 21